5 FDA Decisions for Primary Care to Know from August 2026

In August, the US Food and Drug Administration (FDA) issued new approvals for HIV switch therapy, seasonal influenza vaccination, narcolepsy type 1, and cardiovascular risk reduction in type 2 diabetes, along with regulatory review of an expanded RSV prevention indication for high-risk children.